NEW YORK (GenomeWeb News) - Roche Diagnostics has agreed to a settlement offer from Ambry Genetics in a case involving patent infringement for Roche’s polymerase chain reaction and related technology, Roche said today.
Under the settlement, Roche has agreed to drop arbitration proceedings against the Ambry in return for payment of past royalties of an undisclosed amount in the field of human in vitro diagnostics.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.